David P Schenkein Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

David P Schenkein is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 282 shares of REGN, which is worth approximately $232,503. The most recent transaction as insider was on Jan 02, 2024, when has been sold 42 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 282

0% 3M change

17.5% 12M change

Total Value Held $232,503

David P Schenkein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 02 2024	BUY Grant, award, or other acquisition	-	42 Added 12.96%	282 Common Stock
Sep 08 2023	BUY Grant, award, or other acquisition	-	240 Added 50.0%	240 Common Stock

Also insider at

DNLI

Denali Therapeutics Inc. Healthcare

Director

AGIO

AGIOS PHARMACEUTICALS, INC. Healthcare

Director

PRME

Prime Medicine, Inc.

Director

DPS